OAC
CRBU icon

OMERS Administration Corp’s Caribou Biosciences CRBU Stock Holding History

OMERS Administration Corp’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-120,200
Closed -$228K – 970
2026
Q1 		$228K Sell
120,200
-57,900
-33% -$99.4K ﹤0.01% 890
2025
Q4 		$283K Buy
+178,100
New +$374K ﹤0.01% 826

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OMERS Administration Corp's CRBU Position: Q2 2026 in Review

OMERS Administration Corp sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 120,200 shares — an estimated $228K sold.

OMERS Administration Corp first reported a position in CRBU in Q4 2025 and held it in 2 quarters. The position peaked at $283K in Q4 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • OMERS Administration Corp reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 120,200 Caribou Biosciences shares in Q2 2026, an estimated $228K.
  • OMERS Administration Corp first reported a position in Caribou Biosciences in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Caribou Biosciences position peaked at $283K in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.